ArticleMolecular cancer therapeutics2013

Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.

Bhawna Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.